Hormonal Regulation of Nitric Oxide (NO) in Cardio-metabolic Diseases

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|23|10|1427-1434

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.23, Iss.10, 2017-05, pp. : 1427-1434

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Regulation of Na+/K+-ATPase by Estradiol and IGF-1 in Cardio-Metabolic Diseases

By  

Current Pharmaceutical Design, Vol. 23, Iss. 10, 2017-05 ,pp. : 1551-1561

Bentham Science Publishers

Access to resources Recommend Favorite

Editorial: The Different Facets of Diabetes, Dyslipidemia and Hypertension in Cardio-metabolic Diseases: Current Perspective and Future Developments

By  

Current Pharmaceutical Design, Vol. 23, Iss. 10, 2017-05 ,pp. : 1425-1426

Bentham Science Publishers

Access to resources Recommend Favorite

Neuro-Hormonal Regulation of Immune and Metabolic Function

By  

Current Medicinal Chemistry - Anti-Inflammatory & Anti-Allergy Agents, Vol. 4, Iss. 6, 2005-12 ,pp. : 625-629

Bentham Science Publishers

Access to resources Recommend Favorite

Role of nitric oxide in rat coronary flow regulation during respiratory and metabolic acidosis

By Song D.   O'Regan M.H.   Phillis J.W.  

General Pharmacology, Vol. 32, Iss. 5, 1999-05 ,pp. : 571-575

Elsevier

Access to resources Recommend Favorite

Type II nitric oxide synthase activity is cardio-protective in experimental sepsis

By Price S.   Mitchell J.A.   Anning P.B.   Evans T.W.  

European Journal of Pharmacology, Vol. 472, Iss. 1, 2003-07 ,pp. : 111-118

Elsevier

Access to resources Recommend Favorite